CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer.
Lei H, Wang Z, Jiang D, Liu F, Liu M, Lei X, Yang Y, He B, Yan M, Huang H, Liu Q, Pang J.
Lei H, et al. Among authors: liu m, liu q, liu f.
Cell Death Dis. 2021 Jul 27;12(8):740. doi: 10.1038/s41419-021-04027-6.
Cell Death Dis. 2021.
PMID: 34315855
Free PMC article.